相关实验视频
Updated: Jun 24, 2025
13:00
Engineering Antiviral Agents via Surface Plasmon Resonance
Published on: June 14, 2022
2.3K
针对曼诺酶受体的药物供应以改善抗艾滋病毒治疗的现状
Satish Rojekar1, Amol D Gholap2, Namdev Togre3
1Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
概括
针对免疫细胞上的曼诺斯受体,为增强艾滋病毒治疗提供了一个新的策略. 本综述探讨了先进的药物输送系统,如纳米颗粒,以提高抗艾滋病毒药物疗效和减少副作用.
科学领域:
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
- 纳米技术 纳米技术
背景情况:
- 巨细胞和树突细胞上的曼诺酶受体与HIV病原发生有关.
- 准这些受体为改善艾滋病毒药物输送提供了机会.
- 目前的艾滋病毒治疗面临的挑战是特异性和系统性毒性.
研究的目的:
- 综合审查用于艾滋病毒治疗的向曼诺酶受体药物输送系统的进展.
- 评估各种纳米载体平台在增强抗艾滋病毒治疗方面的潜力.
- 讨论曼诺斯受体与艾滋病毒之间的相互作用,以优化药物输送.
主要方法:
- 对针对曼诺酶受体的纳米载体系统 (纳米颗粒,脂质体,菌体,树枝状体) 的最新文献进行系统审查.
- 通过纳米载体识别曼诺酶受体的设计原则的分析.
- 对物理化学性质对药物输送性能和抗HIV药物的药理动力学/药理动力学影响的评估.
主要成果:
- 不同的纳米载体系统显示有望针对性地传递给曼诺斯受体.
- 有针对性的治疗提高了抗艾滋病毒药物的特异性,生物可用性和治疗疗效.
- 了解曼诺斯受体与艾滋病毒的相互作用有助于设计有效的药物输送平台.
结论:
- 基于曼诺斯受体的药物输送是推动艾滋病毒治疗的有希望的策略.
- 新型纳米载体系统可以克服当前疗法的局限性,从而产生更有效的治疗方法.
- 对于临床翻译,需要对免疫性和可扩展性等挑战进行进一步的研究.
相关概念视频
01:26Targets for Drug Action: Overview
6.2K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.2K
01:06Carrier-Mediated Transport
355
Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
355
01:39Receptor-mediated Endocytosis
104.3K
Overview
104.3K
01:23Mechanisms of Drug Absorption: Paracellular, Transcellular, and Vesicular Transport
513
Drugs need to permeate cell membranes to reach their target sites after administration. Orally administered drugs must transcend intestinal epithelial membrane barriers to infiltrate the systemic circulation. Drugs with a molecular weight of less than 500 Daltons diffuse through gaps between neighboring cells, called paracellular pathways.
However, most drugs use the transcellular route, traversing directly through the cell membranes via two mechanisms: passive and active transport. Passive...
However, most drugs use the transcellular route, traversing directly through the cell membranes via two mechanisms: passive and active transport. Passive...
513
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
01:19Drug Absorption Mechanism: Carrier-Mediated Membrane Transport
3.7K
Certain large, lipid-insoluble drug molecules that resemble amino acids, peptides, or glucose, require specialized carrier proteins to facilitate their diffusion across cell membranes. This transport can occur through either facilitated diffusion, which does not require energy input, or active transport, which does require energy input.
Facilitated diffusion is a passive process that utilizes human Solute Carrier (SLC) transporters. These transporters bind to the drug, undergo structural...
Facilitated diffusion is a passive process that utilizes human Solute Carrier (SLC) transporters. These transporters bind to the drug, undergo structural...
3.7K